Preetesh Jain Guilin Tang Sergej N Konoplev Rashmi Kanagal-Shamanna Sa A Wang Naveen Pemmaraju Naval Daver Zeev Estrov
10.1002/ajh.24208
Am J Hematol
2016 Mar;91(3):354-5.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/26437693/
DNA-Binding Proteins / genetics Leukemia, B-Cell / genetics Myelodysplastic Syndromes / genetics Proto-Oncogene Proteins / genetics Tumor Suppressor Protein p53 / genetics
DNA-Binding Proteins / genetics Leukemia, B-Cell / genetics Myelodysplastic Syndromes / genetics Proto-Oncogene Proteins / genetics Tumor Suppressor Protein p53 / genetics Case Reports Research Support, N.I.H., Extramural Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols / administration & dosage Antineoplastic Combined Chemotherapy Protocols / therapeutic use Bone Marrow / pathology Cytogenetic Analysis Dioxygenases Female Humans In Situ Hybridization, Fluorescence Leukemia, B-Cell / complications Leukemia, B-Cell / drug therapy Mutation Myelodysplastic Syndromes / complications Myelodysplastic Syndromes / drug therapy Treatment Outcome DNA-Binding Proteins Proto-Oncogene Proteins TP53 protein, human Tumor Suppressor Protein p53 Dioxygenases TET2 protein, human
PMC4764477
26437693
Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations
2016